Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
- Released
- 2026-10-29 16:46
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Your picks build your own list. Add items to lists and rank them.
Theme
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.